Current Cancer Therapy Reviews


Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 13 Issue: 2, August 2017

Meet Our Editorial Board Member free to download

Volume:13   Issue: 2
Pp: 75-75
Jing Cai
DOI: 10.2174/157339471302171115152024
Published on: 15 November, 2017

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target open access plus

Volume:13   Issue: 2
Pp: 76-88
Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*
DOI: 10.2174/1573394713666170907160734
Published on: 07 September, 2017

Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy

Volume:13   Issue: 2
Pp: 89-106
Pritish Nilendu, Sayantani Roychoudhary, Karishma Deshpande and Nilesh K. Sharma*
DOI: 10.2174/1573394713666170615115259
Published on: 15 June, 2017

PDE5 Inhibitors Offer Novel Mechanisms in Combination and Solo Cancer Therapy

Volume:13   Issue: 2
Pp: 107-119
Robert W. Lyday , Abigail M. Etters, Chris Kim, Fernando Magana, Gabriel M. Pontipiedra, Naveen K.M. Singh and Samuel Kadavakollu *
DOI: 10.2174/1573394713666170731152749
Published on: 31 July, 2017

Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway

Volume:13   Issue: 2
Pp: 120-128
Yijun Huang* and Hong Zhang
DOI: 10.2174/1573394713666170824125158
Published on: 24 August, 2017

In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells open access plus

Volume:13   Issue: 2
Pp: 129-136
Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi
DOI: 10.2174/1573394713666170712113049
Published on: 12 July, 2017

Acknowledgements to Reviewers free to download

Volume:13   Issue: 2
Pp: 137-137
DOI: 10.2174/157339471302171115152114
Published on: 15 November, 2017